Turnstone Biologics (TSBX) Ownership - Who owns Turnstone Biologics?
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TSBX showed earnings on May 09, 2025. You can read more about the earnings report here.